Glow Medispa, LLC dba Mint Med
Has Glow Medispa, LLC dba Mint Med received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued Glow Medispa, LLC dba Mint Med a warning letter naming semaglutide and tirzepatide, dated Jun 8, 2026, with the FDA subject line “False & Misleading Claims/Misbranded (Telehealth).”
FDA records in this index name Glow Medispa, LLC dba Mint Med on Jun 8, 2026.
- Websites the letters name
- mintmed.com (see how each letter refers to them)
- Type named in FDA records
- Telehealth
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Tirzepatide
- Latest record
- Jun 8, 2026
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Jun 8, 2026 | False & Misleading Claims/Misbranded (Telehealth) | Semaglutide, Tirzepatide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Jun 8, 2026: … your website offers compounded drug products, including semaglutide and tirzepatide products. 1 As described below, … website’s false or misleading claims concerning compounded semaglutide and tirzepatide products under sections 502(a) … or operations. Your representations regarding compounded semaglutide and tirzepatide products are false or misleading. … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- mintmed.com: FDA’s warning letter of Jun 8, 2026 is addressed to Glow Medispa, LLC dba Mint Med. It refers to the site in these words: “FDA Review Violations were identified and documented during a review of Mint Med’s website, https://mintmed.com, FDA Establishment Identifier (FEI) 3044896930, in May 2026.” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.